A pilot study to estimate the feasibility of assessing the relationships between polymoprhisms in hKv1.5 and atrial fibrillation in patients following coronary artery bypass graft surgery

Canadian Journal of Cardiology

Volumn 24, Issue 1, 2008, Pages 41-44

  Plante, Isabelle ^a,b   Fournier, Dominique ^a   Mathieu, Patrick ^a,b   Daleau, Pascal ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

hKv1.5; Postoperative atrial fibrillation; Potassium channels; Single nucleotide polymorphism

Indexed keywords

POTASSIUM CHANNEL KV1.5;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PILOT STUDY; PREVALENCE; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 40749118480     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(08)70546-4     Document Type: Article

References (27)

1. Fuller JA, Adams GG, Buxton B. Atrial fibrillation after coronary artery bypass grafting. Is it a disorder of the elderly? J Thorac Cardiovasc Surg 1989;97:821-5.
2. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation 1998;98:946-52.
3. Chung MK, Martin DO, Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias: Inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001;104:2886-91.
4. Lévy S. Epidemiology and classification of atrial fibrillation. J Cardiovasc Electrophysiol 1998;9:S78-82.
5. Kolvekar S, D'Souza A, Akhtar P, Reek C, Garratt C, Spyt T. Role of atrial ischaemia in development of atrial fibrillation following coronary artery by-pass surgery. Eur J Cardiothorac Surg 1997;11:70-5.
6. 2+ currents and human atrial fibrillation. Circ Res 1999;85:428-36.
7. Dupont E, Ko Y, Rothery S, et al. The gap-junctional protein connexin40 is elevated in patients susceptible to postoperative atrial fibrillation. Circulation 2001;103:842-9.
8. Mandal K, Jahangiri M, Mukhin M, Poloniecki J, Camm AJ, Xu Q. Association of anti-heat shock protein 65 antibodies with development of postoperative atrial fibrillation. Circulation 2004;110:2588-90.
9. Mihm MJ, Yu F, Carnes CA, et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 2001;104:174-80.
10. Carnes CA, Chung MK, Nakayama T, et al. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ, Res 2001;89:E32-8.
11. Gaudino M, Andreotti F, Zamparelli R, et al. The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication? Circulation 2003;108(Suppl 1):II195-9.
12. + channel current. Circ Res 1993;73:210-6.
13. Plante I, Fournier D, Ricard G, et al. Electrophysiological characterization of three non-synonymous single nucleotide polymorphisms (R87Q, A251T, and P307S) found in hKv1.5. Pflugers Arch 2006;452:316-23.
14. + channel gene KCNA5. Clin Pharmacol Ther 2005; 77:138-44.
15. Olson TM, Alekseev AE, Liu XK, et al. Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation. Hum Mol Genet 2006;15:2185-91.
16. Chen YH, Xu SJ, Bendahhou S, et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 2003;299:251-4.
17. Hong K, Piper DR, Diaz-Valdecantos A, et al. De novo KCNQ1 mutation responsible for atrial fibrillation and short QT syndrome in utero. Cardiovasc Res 2005;68:433-40.
18. Xia M, Jin Q, Bendahhou S, et al. A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation. Biochem Biophys Res Commun 2005;332:1012-9.
19. Yang Y, Xia M, Jin Q, et al. Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. Am J Hum Genet 2004;75:899-905.
20. Vandenbroucke JP, Koster T, Briët E, Reitsma PH, Bertina RM, Rosendaal FR. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994;344:1453-7.
21. van Asselt KM, Kok HS, van der Schouw YT, Peeters PH, Pearson PL, Grobbee DE. Role of genetic analyses in cardiology: Part II: Heritability estimation for gene searching in multifactorial diseases. Circulation 2006;113:1136-9.
22. Caouette D, Dongmo C, Bérubé J, Fournier D, Daleau P. Hydrogen peroxide modulates the Kv1.5 channel expressed in a mammalian cell line. Naunyn Schmiedebergs Arch Pharmacol 2003;368:479-86.
23. Kopecky SL, Gersh BJ, McGoon MD, et al. The natural history of lone atrial fibrillation. A population-based study over three decades. N Engl J Med 1987;317:669-74.
24. Darbar D, Herron KJ, Ballew JD, et al. Familial atrial fibrillation is a genetically heterogeneous disorder. J Am Coll Cardiol 2003;41:2185-92.
25. Roberts R. Mechanisms of disease: Genetic mechanisms of atrial fibrillation. Nat Clin Pract Cardiovasc Med 2006;3:276-82.
26. Tsai CT, Lai LP, Lin JL, et al. Renin-angiotensin system gene polymorphisms and atrial fibrillation. Circulation 2004;109:1640-6.
27. Firouzi M, Ramanna H, Kok B, et al. Association of human connexin40 gene polymorphisms with atrial vulnerability as a risk factor for idiopathic atrial fibrillation. Circ Res 2004;95:e29-33.